Amgen shares are trading lower after the company reported mixed Q3 financial results and issued FY23 guidance.
Portfolio Pulse from Benzinga Newsdesk
Amgen reported mixed Q3 financial results and issued FY23 guidance, leading to a decrease in its share price.
October 31, 2023 | 5:54 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Amgen's shares are trading lower due to mixed Q3 results and FY23 guidance.
Amgen's mixed Q3 financial results and the issuance of FY23 guidance have not been well received by the market, leading to a decrease in its share price. This indicates that investors may have had higher expectations for the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100